Abound Secures $14 Million in Funding on March 27, 2025
NEAR
NEAR
-2.72%
According to industry sources, cross-border remittance platform Abound secured $14 million in funding on March 27, 2025. Investors in this round include NEAR Foundation, Circle Ventures, and Times Internet. With this latest financing, Abound’s total funding has reached $14 million.Abound, a cross-border remittance platform backed by The Times of India, was established in 2023 and primarily focuses on providing cross-border remittance services for the Indian diaspora in the United States. As globalization deepens and demand for cross-border payments continues to rise, the cross-border remittance market is demonstrating significant growth potential. Abound’s services not only enable convenient international fund transfers for the Indian community in the US but also reduce the high fees associated with traditional remittance channels and enhance transfer efficiency.Notably, this funding round features participation from prominent blockchain entity NEAR Foundation and Circle Ventures, the investment arm of payment giant Circle. This highlights the accelerating integration of traditional finance and blockchain technology within the cross-border payments sector. The new capital will support Abound in further expanding its market share, optimizing its product offerings, and delivering secure and efficient cross-border remittance solutions to a broader user base.
this-content
disclaimer-th
comment
NEAR fundraising-history
| fundraising-Round | fundraising-amount | fundraising-valuation | fundraising-time | fundraising-investor |
|---|---|---|---|---|
| -- | fundraising-$M | -- | 2025-03-26 | NEAR Foundation,Circle Ventures,Times Internet |
fundraising-key-milestones
- 2025-03-27Abound secured $14 million in its latest funding round.
24hour-high
$2.08
24hour-volume
$4.93M
alltime-high
$20.44
alltime-low
$0.5267
market-cap--f
100%
fdv
$2.05B
24hour-low
$1.88
market-cap
$2.62B
circulating-s
1.27B NEAR
total-supply
1.27B NEAR
max-supply
-- NEAR
market-sentim
--
| 1H | 24H | 7D | 30D | 1Y |
|---|---|---|---|---|
2.96% | 5.75% | 1.25% | 29.79% | 46.31% |
